Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: CYGNOS BIOTECH, LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2025-03-07 to 2025-09-08
Current total value of award: $204493.42
Description: RESEARCH TO CREATE A CLASS OF AGNOSTIC DRUGS TARGETING THE HOST TO ASSIST IN FIGHTING OFF A BROAD SPECTRUM OF VIRAL PATHOGENS.